Hikma Pharmaceuticals Regulatory News (HIK)

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Susan Ringdal

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each (Shares)

ID Code: GB00B0LCW083

b)

Nature of the transaction

Acquisition of Shares pursuant to the exercise of options granted at nil-cost under the 2014 Executive Incentive Plan

c)

Price(s) and volume(s)

Price(s): nil

Volume(s): 25,012

d)

Aggregated information

- Volume

- Price

- Total

 25,012

 nil

 nil

e)

Date of the transaction

10 August 2023

f)

Place of the transaction

Outside a trading venue

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

 Description: Ordinary shares of 10 pence each (Shares)

 ID Code: GB00B0LCW083

b)

Nature of the transaction

Sale of Shares

c)

Price(s) and volume(s)

Price(s): £22.03

Volume(s): 25,012

d)

Aggregated information

- Volume

- Price

- Total

 25,012

 £22.03

 £551,208.96

e)

Date of the transaction

 10 August 2023

f)

Place of the transaction

 London Stock Exchange (XLON)